Considering the multiple protective effects of Timp4 gene deletion against obesity and associated comorbidities, targeted inhibition of TIMP4 could be a promising therapeutic target against obesity. This evidence concerns the gene TIMP4 and obesity due to melanocortin 4 receptor deficiency.